Published in Oncogene on May 30, 2011
MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem (2012) 1.30
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation. Oncotarget (2014) 0.98
Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PLoS One (2011) 0.89
A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation. Proc Natl Acad Sci U S A (2015) 0.85
Use of lectin microarray to differentiate gastric cancer from gastric ulcer. World J Gastroenterol (2014) 0.83
Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma. Tumour Biol (2015) 0.81
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Mol Cancer (2015) 0.81
Deconstruction of O-glycosylation-GalNAc-T isoforms direct distinct subsets of the O-glycoproteome. EMBO Rep (2015) 0.80
Trimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin α5β1 and matrix metalloproteinase 9. J Biol Chem (2013) 0.78
Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse. Pharmacol Res Perspect (2013) 0.78
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk. Sci Rep (2015) 0.77
Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans. J Biol Chem (2014) 0.77
Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification. Onco Targets Ther (2015) 0.77
Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer. Front Oncol (2016) 0.77
Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles. Carbohydr Res (2014) 0.76
Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. Br J Cancer (2016) 0.75
Loss of N-acetylgalactosaminyltransferase-4 orchestrate oncogenic microRNA-9 in hepatocellular carcinoma. J Biol Chem (2017) 0.75
MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy. Biomed Res Int (2016) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer (2004) 8.06
Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (1992) 6.13
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology (2002) 4.11
Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res (1989) 3.25
Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta (1999) 2.51
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci (2004) 2.31
Interpreting the protein language using proteomics. Nat Rev Mol Cell Biol (2006) 2.23
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Galectin-3 and metastasis. Glycoconj J (2004) 1.84
Coupling of bitter receptor to phosphodiesterase through transducin in taste receptor cells. Nature (1995) 1.83
Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology (2005) 1.78
Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer (2004) 1.77
Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem (1995) 1.60
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Lab Invest (2005) 1.59
cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. J Biol Chem (1996) 1.46
Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci (2004) 1.36
Subunit dissociation and diffusion determine the subcellular localization of rod and cone transducins. J Neurosci (2007) 1.35
Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res (1987) 1.29
Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov (2005) 1.22
Glycan changes: cancer metastasis and anti-cancer vaccines. J Biosci (2010) 1.14
Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development. Development (1992) 1.13
Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res (1999) 1.05
O-sialoglycoprotease from Pasteurella haemolytica. Methods Enzymol (1995) 1.04
Display and analysis of flow cytometric data. Annu Rev Biophys Bioeng (1980) 1.00
The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr Pharm Biotechnol (2001) 0.99
Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res (1997) 0.99
Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest (2008) 0.91
From glycomics to functional glycomics of sugar chains: Identification of target proteins with functional changes using gene targeting mice and knock down cells of FUT8 as examples. Biochim Biophys Acta (2006) 0.82
Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol (2001) 4.82
S. cerevisiae encodes an essential protein homologous in sequence and function to mammalian BiP. Cell (1989) 4.28
Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A (1997) 3.53
A 22 bp cis-acting element is necessary and sufficient for the induction of the yeast KAR2 (BiP) gene by unfolded proteins. EMBO J (1992) 3.48
Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci U S A (1994) 3.09
Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation (1997) 3.04
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol (1999) 2.93
Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeats. Proc Natl Acad Sci U S A (1987) 2.82
Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol (1996) 2.67
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. Nat Cell Biol (2001) 2.23
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development. Genes Dev (2001) 2.18
Dissociation of Kar2p/BiP from an ER sensory molecule, Ire1p, triggers the unfolded protein response in yeast. Biochem Biophys Res Commun (2000) 2.17
Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene. Proc Natl Acad Sci U S A (1987) 2.12
Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology (1996) 2.01
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut (2003) 2.00
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer (2008) 1.93
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res (1996) 1.90
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene (2009) 1.85
Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res (1995) 1.76
Antibodies against 70-kD heat shock cognate protein inhibit mediated nuclear import of karyophilic proteins. J Cell Biol (1992) 1.74
Molecular characterization of two Arabidopsis Ire1 homologs, endoplasmic reticulum-located transmembrane protein kinases. Plant Physiol (2001) 1.73
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem (1997) 1.72
Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64
Identification of the V factor needed for synthesis of the iron-molybdenum cofactor of nitrogenase as homocitrate. Nature (1987) 1.64
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther (2002) 1.62
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res (1998) 1.59
Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem (1997) 1.59
Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci (2001) 1.59
Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med (1999) 1.58
Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab (1995) 1.52
Histone-like proteins are required for cell growth and constraint of supercoils in DNA. Gene (1992) 1.50
Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia (2006) 1.49
Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res (2001) 1.49
MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol (1998) 1.47
Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors. Hum Pathol (1997) 1.45
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res (1995) 1.43
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42
Recombinant high molecular weight-glutenin subunit-specific IgE detection is useful in identifying wheat-dependent exercise-induced anaphylaxis complementary to recombinant omega-5 gliadin-specific IgE test. Clin Exp Allergy (2012) 1.42
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res (1999) 1.38
Isolation and characterization of a cDNA clone for the amino-terminal portion of the pro-alpha 1(II) chain of cartilage collagen. J Biol Chem (1984) 1.38
Meiotic behaviours of chromosomes and microtubules in budding yeast: relocalization of centromeres and telomeres during meiotic prophase. Genes Cells (1998) 1.38
Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas. Int J Cancer (1999) 1.37
Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest (2000) 1.35
High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun (1999) 1.35
Identification of MUC1 proteolytic cleavage sites in vivo. Biochem Biophys Res Commun (2001) 1.34
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem (1998) 1.34
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res (2001) 1.33
Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res (1996) 1.33
Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp. J Med Chem (1991) 1.32
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene (2007) 1.32
Mesalazine-induced eosinophilic pneumonia. Respiration (1999) 1.31
A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem (1996) 1.31
Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis (1993) 1.30
Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer (2000) 1.27
The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. J Biol Chem (2000) 1.26
Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem (1998) 1.25
Regulation of the collagen II gene in vitro and in transgenic mice. Ann N Y Acad Sci (1990) 1.23
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene (2010) 1.23
Structure of the promoter of the rat type II procollagen gene. J Biol Chem (1985) 1.23
Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett (1997) 1.22
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene (2000) 1.21
Purification and characterization of BiP/Kar2 protein from Saccharomyces cerevisiae. J Biol Chem (1992) 1.20
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer (2004) 1.19
Cry j I, a major allergen of Japanese cedar pollen, has pectate lyase enzyme activity. Allergy (1995) 1.19
Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene (2008) 1.18
Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem (1997) 1.18
Development of hepatic sinusoidal structure with special reference to the Ito cells. Microsc Res Tech (1997) 1.17
Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol (2003) 1.17
Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet (1998) 1.17
Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol (1999) 1.15
Changes of relaxation times (T1, T2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution, regional extent, and comparison with histology. Magn Reson Med (1995) 1.13
ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes. Oncogene (2007) 1.13
The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res (1999) 1.13
Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells. Biochem Biophys Res Commun (2000) 1.13
The incidence and developmental process of delayed traumatic intracerebral haematomas. Acta Neurochir (Wien) (1985) 1.12
Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergy (2008) 1.12
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res (1998) 1.12
Elongation factor 2 mutants deficient in diphthamide formation show temperature-sensitive cell growth. J Biol Chem (1994) 1.12
Thermosensitivity of green fluorescent protein fluorescence utilized to reveal novel nuclear-like compartments in a mutant nucleoporin NSP1. J Biochem (1995) 1.11
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene (2006) 1.11
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene (2006) 1.11
Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J Biol Chem (2000) 1.11
A novel mutation which enhances the fluorescence of green fluorescent protein at high temperatures. Biochem Biophys Res Commun (1997) 1.10
A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett (1999) 1.10
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem (1998) 1.10
Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke (1998) 1.10
Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab (1994) 1.10
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. Nucleic Acids Res (2001) 1.09
Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem (2000) 1.09
In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother (1997) 1.09
Construction of a bovine yeast artificial chromosome (YAC) library. Anim Genet (1998) 1.08
Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer (1999) 1.08
Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer (2001) 1.08
Complete nucleotide sequence and characterization of the 5'-flanking region of mammalian elongation factor 2 gene. J Biol Chem (1988) 1.08
Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. Int J Cancer (2001) 1.08